Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T83006 |
Antitumor agent-29
|
||
Antitumor agent-29为新型肝细胞靶向抗肿瘤前体,表现出优异抗肿瘤活性及低毒性副作用。 | |||
T3437 |
Lys05
Lys01 trihydrochloride |
lysosomal autophagy; Autophagy | Autophagy |
Lys05 是一种有效的水溶性溶酶体自噬抑制剂,具有抗肿瘤活性。在 MTT 试验中,对1205Lu、c8161、LN229 和 HT-29细胞系的IC50值分别为3.6、3.8、6 和7.9 μM。 | |||
T83008 |
Antitumor agent-119
|
||
Antitumor agent-119(化合物13K)为2-苯并恶唑基腙衍生物,显示抗癌活性。该化合物对Butkitt、CCRF-CEM、HeLa和HT-29细胞系展现出细胞生长抑制作用,其IC50值分别为30 nM、140 nM、100 nM和40 nM。 | |||
T12925 |
Sitravatinib malate
MGCD516 malate,MG-516 malate |
TAM Receptor | Tyrosine Kinase/Adaptors |
Sitravatinib malate is an orally bioavailable receptor inhibitor of tyrosine kinase (RTK) (IC50s of 1.5 nM, 2 nM, 2 nM, 5 nM, 6 nM, 6 nM, 8 nM, 0.5 nM, 29 nM, 5 nM, and 9 nM for Axl, MER, VEGFR3, VEGFR2, VEGFR1, KIT, FLT3, DDR2, DDR1, TRKA, TRKB, respectively.) , shows potent single-agent antitumor efficacy and enhances the activity of PD-1 blockade through promoting an antitumor immune microenvironment. |